Regenex for Research Partners
Regenex Asia actively seeks research collaborations with universities, research hospitals and pharmaceutical companies. We provide consistent, cGMP-manufactured cell therapy products for research use and bring manufacturing expertise to collaborative clinical studies and product development programmes.
Our existing research partnerships with the University of Malaya and Universiti Kebangsaan Malaysia (UKM) have produced published studies and active clinical protocols across multiple therapeutic areas. We're looking to expand this model to new partners and new research questions.
What We Bring to Research Collaborations
cGMP-Manufactured Research Products
Consistent, quality-controlled MSC, NK cell and exosome products for research use. Batch-to-batch reproducibility is critical for meaningful research — our Passage 2, pooled-donor products deliver it.
Manufacturing Expertise
Our scientific team contributes cell biology, manufacturing process and quality control expertise to collaborative research designs. We support protocol development, feasibility assessment and scale-up planning.
Clinical Protocol Support
For translational research involving patient treatment, we provide the manufacturing infrastructure, quality documentation and regulatory compliance framework needed to conduct clinical studies.
Published Track Record
Our collaborations with University of Malaya and UKM have resulted in published, peer-reviewed research. We bring a track record of productive academic partnership.
Research Areas of Interest
Current Research Partnerships
University of Malaya
Active collaboration spanning MSC biology, exosome characterisation and clinical protocol development. Published studies in peer-reviewed journals.
Universiti Kebangsaan Malaysia (UKM)
Research partnership focused on translational cell therapy applications and quality standardisation.
How to Propose a Collaboration
Submit Proposal
Submit a partner enquiry describing your institution, research area of interest and proposed collaboration scope.
Scientific Review
Our scientific team reviews the proposal and arranges an initial discussion.
Collaboration Framework
We develop a framework covering research objectives, product supply, IP arrangements, publication rights and funding.
Collaboration Begins
Work begins once the agreement is formalised by both parties.
We welcome proposals from established research institutions worldwide. Early-stage companies and PhD candidates with relevant projects are also encouraged to reach out.
Partner With Us on Cell Therapy Research
Our scientific team is ready to discuss collaborative opportunities in regenerative medicine, immunotherapy and beyond.